You just read:

Zealand Pharma and Boehringer Ingelheim Enter Into a Licence and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity

News provided by

Zealand Pharma A/S

16 Jun, 2011, 07:09 BST